Baxter J D, Schambelan M, Matulich D T, Spindler B J, Taylor A A, Bartter F C
J Clin Invest. 1976 Sep;58(3):579-89. doi: 10.1172/JCI108504.
Aldosterone receptors from rat kidney slices were utilized in a competitive binding technique to analyze the contribution of various steroids to plasma "mineralocorticoid" activity and to assess their possible role in hypertension. To consider simultaneously the plasma binding, steroids were incubated with slices in undiluted plasma; competitor activities for [3H]aldosterone binding were aldosterone, 100%; deoxycorticosterone, 16.2%; cortisol, 0.4%; and 18-hydroxy-deoxy-corticosterone and d18-hydroxy-corticosterone, 0.1%. These steroids were more active in buffer than plasma, suggesting that they bind to plasma and that this reduces their receptor binding. Analysis of the competition data suggests that at normal plasma concentrations, aldosterone occupies the receptors to a major extent, cortisol occupies some of the receptors, and deoxycorticosterone and 8-hydroxydeoxycorticosterone contribute little to receptor occupancy. Two steroids implicated in low-renin essential hypertension, 16beta-hydroxy-dehydro-epiandrosterone and 16-oxoandrostenediol, did not have significant competitor activity. Competitor activity in plasmas from normal subjects taken at 12 noon (upright) was greater than that in those taken at 8 a.m. (supine). Since the 12 noon samples had higher aldosterone and lower cortisol levels than the 8 a.m. samples, the competitor activity under these physiological circumstances reflects aldosterone more than cortisol. The competitor activities of plasmas from patients relative to normal subjects (100+/-12.1%; mean+/-SEM) were: normal renin "essential" hypertension, 117+/-14%; low-renin essential hypertension, 101+/-6.6%; and primary aldosteronism, 176+/-14.3%. Thus a significant increase in activity of steroids that interact with mineralocorticoid receptors was detected in primary aldosteronism (P LESS THAN 0.01) BUT WAS NOT DETECTED IN LOW-RENIN OR NORMAL-RENIN ESSENTIAL HYPERTENSION.
利用大鼠肾切片中的醛固酮受体,采用竞争性结合技术分析各种类固醇对血浆“盐皮质激素”活性的贡献,并评估它们在高血压中可能发挥的作用。为了同时考虑血浆结合情况,将类固醇与未稀释血浆中的切片一起孵育;[3H]醛固酮结合的竞争活性分别为:醛固酮,100%;脱氧皮质酮,16.2%;皮质醇,0.4%;18-羟基脱氧皮质酮和d18-羟基皮质酮,0.1%。这些类固醇在缓冲液中的活性比在血浆中更高,这表明它们与血浆结合,从而降低了它们与受体的结合。对竞争数据的分析表明,在正常血浆浓度下,醛固酮在很大程度上占据受体,皮质醇占据一些受体,而脱氧皮质酮和8-羟基脱氧皮质酮对受体占据的贡献很小。与低肾素原发性高血压有关的两种类固醇,16β-羟基脱氢表雄酮和16-氧代雄烯二醇,没有显著的竞争活性。中午12点(直立位)采集的正常受试者血浆中的竞争活性高于上午8点(仰卧位)采集的血浆。由于中午12点的样本比上午8点的样本醛固酮水平更高、皮质醇水平更低,在这些生理情况下的竞争活性更多地反映醛固酮而非皮质醇。患者血浆相对于正常受试者的竞争活性(100±12.1%;平均值±标准误)分别为:正常肾素“原发性”高血压,117±14%;低肾素原发性高血压,101±6.6%;原发性醛固酮增多症,176±14.3%。因此,在原发性醛固酮增多症中检测到与盐皮质激素受体相互作用的类固醇活性显著增加(P<0.01),但在低肾素或正常肾素原发性高血压中未检测到。